MedPath

Effect of lignocaine on biological markers in bowel surgery

Phase 4
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/03/032273
Lead Sponsor
Government medical college and hospital Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.ASA (American Society of Anesthesiologists) grade I-II patients

2.Patients scheduled to undergo restoration of bowel continuity

Exclusion Criteria

1.Cardiac conduction abnormalities and congestive heart failure

2.Renal or hepatic impairment

3.Neurological disorders

4.Pregnant and lactating women

5.Patients not able to understand VAS

6.History of substance abuse

7.Contraindications to study drugs: lignocaine, paracetamol ,tramadol and diclofenac

8.Chronic pain conditions, neurodegenerative or autoimmune disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum lactate dehydrogenase (LDH) and lactate levelsTimepoint: Baseline before surgery, before extubation, after 6h ,24h
Secondary Outcome Measures
NameTimeMethod
1.Visual analogue scale at rest and on movement <br/ ><br>2.Time to rescue analgesia and total rescue analgesia <br/ ><br>3.Arterial blood gas(ABG) analysis <br/ ><br>4.Haemodynamics <br/ ><br>Timepoint: 1. VAS score: baseline, post extubation, 1h in postoperative care unit (PACU), at 6h, 12 h and 24 h. <br/ ><br>2. Time to first rescue and total analgesia: in PACU and in postoperative period upto <br/ ><br>24 h. <br/ ><br>3. Baseline before surgery, before extubation, after 6h ,24h <br/ ><br>4.Haemodynamics (PR, BP,RR): baseline, at time of induction, after intubation, every 5 minutes during surgery, at time of extubation, every 5 minutes for 15 min, every 15 minutes upto 1 h in PACU, then in ward at 6 h, 12 h and 24 h. <br/ ><br> <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath